Dietary folate suppresses DMH-induced colon carcinogenesis in a rat model and affects DMH-induced expression of four DNA repair enzymes

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1196-1203

  Sadik, Nermin A H ^a   Shaker, Olfat G ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

5,8 OXOGUANINE DNA GLYCOSYLASE; APURINIC APYRIMIDINIC ENDONUCLEASE 1; CYCLINE; DEOXYRIBONUCLEASE I; DIMETHYLHYDRAZINE; DNA GLYCOSYLTRANSFERASE; FOLIC ACID; MESSENGER RNA; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; XRCC5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; DRUG MECHANISM; DRUG TISSUE LEVEL; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; UPREGULATION;

ANIMALS; COLON; COLONIC NEOPLASMS; DIET; DIETARY SUPPLEMENTS; DIMETHYLHYDRAZINES; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; FOLIC ACID; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; UP-REGULATION;

EID: 84873671268     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.718030     Document Type: Article

References (52)

1. Parkin DM, Bray F, Ferlay J, and Pisani P: Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 94, 153-156, 2001.
2. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al.: The genomic landscape of human breast and colorectal cancers. Science 318(5853), 1108-1113, 2007.
3. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al.: Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 105, 16224-16229, 2008.
4. Levin B: Nutrition and colorectal cancer. Cancer 70, 1723-1726, 1992.
5. Bernstein H, Bernstein C, Payne CM, Dvorakova K, and Garewal H: Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589, 47-65, 2005.
6. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, et al.: Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 85, 863-871, 2011.
7. Kim YI, Salomon RN, Graeme-Cook F, Choi SW, Smith DE, et al.: Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39, 732-740, 1996.
8. Kim Y-I: Folate and carcinogenesis: evidence, mechanisms and implications. J Nutr Biochem 10, 66-88, 1999.
9. Kim YI: Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51, 267-792, 2007.
10. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, and Brezezinski A: The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112, 29-32, 1997.
11. Ekbom A, Helmick C, Zack M, and Adami H-O: Ulcerative colitis and colorectal cancer. Apopulation-based study. N Engl JMed 323, 1228-1233, 1990.
12. Charles D, Ness AR, Campbell D, Smith GD, and Hall MH: Taking folate in pregnancy and risk of maternal breast cancer. BMJ 329, 1375-1376, 2004.
13. Mason JB, Dickstein A, Jacques PF, et al.: A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16, 1325-1329, 2007.
14. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, et al.: Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 101, 432-435, 2009.
15. Wagner C: Biochemical role of folate in cellular metabolism. In: Folate in Health and Disease, Bailey LB (ed). New York: Marcel Dekker 1995, pp. 23-42.
16. Rogers AE and Nauss KM: Rodent models for carcinoma of the colon. Dig Dis Sci 30(12), 87S-102S, 1985.
17. Autrup H and William GM: Experimental Colon Carcinogenesis. CRC Press, Boca Raton, FL, 1983.
18. Sharma P, Kaur J, and Sanyal, SN: Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1, 2 dimethyl hydrazine induced colon carcinogenesis in rat model. Nutr Hosp 25(1), 39-48, 2010.
19. Kim YI, Shirwadkar S, Choi SW, Puchyr M, Wang Y, et al.: Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology 119(1), 151-161, 2000.
20. Chomkczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform method. Anal Biochem 162, 156-160, 1987.
21. Hur K, Kim JR, Yoon BI, Lee JK, Choi JH, et al.: Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis. J Vet Sci 1(2), 121-126, 2000.
22. Wang QM, Zhang Y, Yang KM, Zhou HY, and Yang HJ: Wnt/beta-catenin signaling pathway is active in pancreatic development of rat embryo. World J Gastroenterol 28, 12(16), 2615-2619, 2006.
23. Shaker OG, Moustafa W, Essmat S, Abdel-Halim M, and El-Komy M: The role of interleukin-12 in the pathogenesis of psoriasis. Clin Biochem 39(2), 119-125, 2006.
24. Varela-Moreiras G and Selhub J: Long-term folate deficiency alters folate content and distribution differentially in rat tissues. J Nutr 122, 986-991, 1992.
25. Kim YI, Fawaz K, Knox T, Lee YM, Norton R, et al.: Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps. Am J Clin Nutr 68, 866-872, 1998.
26. Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, et al.: Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med 39, 691-694, 2001.
27. Gloria L, Cravo M, Pinto A, de Sousa L S, Chaves P, et al.: DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78, 2300-2306, 1996.
28. Mason JB: Folate and colonic carcinogenesis: searching for a mechanistic understanding. J Nutr Biochem 5, 170-175, 1994.
29. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, et al.: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-3295, 1997.
30. Reidy JA: Folate- and deoxyuridine-sensitive chromatid breakage may result from DNA repair during G2. Mutat Res 192, 217-219, 1987.
31. Choi SW and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr 130, 129-132, 2000.
32. Duthie SJ, Narayanan S, Blum S, Pirie L, and Brand GM: Folate deficiency in vitro induces uracil misincorporation, DNAhypomethylation and inhibits DNA excision repair in immortalised normal human colon epithelial cells. Nutr Cancer 37, 245-251, 2000.
33. Jeltsch A: Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chembiochem 3, 274-293, 2002.
34. Feinberg AP, Gehrke CW, Kuo KC, and Ehrlich M: Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48, 1159-1161, 1988.
35. Ballestar E and Esteller M: The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23, 1103-1109, 2002.
36. Kim YI, Pogribny IP, Basnakian AG, Miller JW, Selhub J, et al.: Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr 65(1), 46-52, 1997.
37. Borek C, Ong A, Morgan WF, and Cleaver JE: Morphological transformation of 10T1/2 mouse embryo cells can be initiated by DNA double-strand breaks alone. Mol Carcinog 4, 243-247, 1991.
38. Hollstein M, Sidransky D, Vogelstein B, and Harris CC: P53 mutations in human cancers. Science 253, 49-53, 1991.
39. Dhur A, Galan P, and Hercberg S: Folate status and the immune system. Prog Food Nutr Sci 15, 43-60, 1991.
40. O'Byrne KJ and Dalgleish AG: Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85, 473-483, 2001.
41. Duthie SJ, Mavrommatis Y, Rucklidge G, Reid M, Duncan G, et al.: The response of human colonocytes to folate deficiency in vitro: functional and proteomic analyses. J Proteome Res 7, 3254-3266, 2008.
42. Courtemanche C, Huang AC, Elson-Schwab I, Kerry N, Ng BY, et al.: Folate deficiency and ionizing radiation cause DNA breaks in primary human lymphocytes: A comparison. FASEB J 18, 209-211, 2004.
43. Nishimura J, Dewa Y, Okamura T, Jin M, Saegusa Y, et al.: Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats. Toxicol Sci 106, 339-349, 2008.
44. Fortini P, Pascucci B, Parlanti E, D'Errico M, Simonelli V, et al.: 8-Oxoguanine DNA damage: at the crossroads of alternative repair pathways. Mutat Res 53, 127-139, 2003.
45. Choi S-W, Kim Y-I, Weitzel JN, and Mason JB: Folate depletion impairs DNA excision repair in the colon of the rat. Gut 43, 93-99, 1998.
46. Cabelof DC, Raffoul JJ, Nakanura J, Kapoor D, Abdalla H, et al.: Imbalanced base excision repair in response to folate deficiency is accelerated by polymerase β haploinsufficiency. J Biol Chem 279, 36504-36513, 2004.
47. James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, et al.: Mechanisms of DNA damage, DNA hypomethylation and tumour progression in the folate/methyl deficient rat model. J Nutr 133, 3740-3747S, 2003.
48. Kovac D, Rubinic M, Krasevic M, Krizanac S, Petrovecki M, et al.: Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer. Anticancer Res 15, 2301-2302, 1995.
49. Hall PA, Levison DA, and Woods LA: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162, 285-294, 1990.
50. Duthie SJ, Grant G, and Narayanan S: Increased uracil misincorporation in lymphocytes from folate-deficient rats. Brit J Cancer 83, 1532-1537, 2000.
51. Basten GP, Duthie SJ, Pirie L, Vaughan N, Hill MH, et al.: Sensitivity of markers of DNA stability and DNArepair activity to folate supplementation in healthy volunteers. Brit J Cancer 94, 1942-1947, 2006.
52. Sie KK, Medline A, van Weel J, Sohn KJ, Choi SW, et al.: Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring. Gut 60, 1687-1694, 2011.